Chronic Kidney Disease Clinical Trial
Official title:
The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status and Other Outcomes
The study objective is to evaluate if a renal specific oral nutrition supplement (ONS) aids in maintaining nutritional status.
This study is an unblinded, prospective, multicenter, single arm study in Taiwan. Eligible
subjects (see inclusion and exclusion criteria in Section 5.2) will receive standard of care
(which includes dietary counseling) and ONS supplementation (1-2 servings/day depending on
subject's needs) for 24 weeks (6 months). A follow up visit (phone call/medical chart review)
will occur 12 months after the study intervention has ended to collect mortality data, to
determine whether or not dialysis was initiated, and if ONS use continued.
Subjects will be informed of the study results when available. Subjects may continue use of
the commercially available study product if it is recommended by their nephrologist, primary
care physician, dietitian, or if the subject chooses.
For this study enrollment is defined as when the subject is stratified and begins to consume
the study product (Study Visit 1, Month 0).
The target population described above may be stratified into the following groups (n=18
evaluable/group):
1. Male CKD Stage 3b-5 without T2DM
2. Male CKD Stage 3b-5 with T2DM
3. Female CKD Stage 3b-5 without T2DM
4. Female CKD Stage 3b-5 with T2DM
In addition, for those subjects enrolled, retrospective data (previous 6 to 12 months)
identical to the study variables will be collected. Retrospective data collection will focus
on the following measures, however, all data points are not expected to be available:
- Serum albumin
- SGA
- Compliance to protein intake guidelines
- Compliance to energy intake guidelines
- Hand grip strength
- Anthropometrics (weight, height, BMI)
- Quality of Life (WHOQOL-BREF Taiwan Version)
- eGFR (whichever equation is used as standard of care)
- Serum creatinine
- Proteinuria (retrospective - if available on medical records)
- BUN
- Body composition data from BIA (especially fat mass and muscle mass, units or exact
terminology will be model specific)
- C reactive protein (CRP)
- Blood chemistries,
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Terminated |
NCT04043026 -
The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
|
||
Completed |
NCT05318014 -
Low-protein Formula Supplements in Chronic Kidney Disease
|
N/A | |
Active, not recruiting |
NCT06071065 -
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
|
N/A | |
Completed |
NCT02878317 -
Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
|
||
Not yet recruiting |
NCT06039254 -
Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function
|
Phase 1 | |
Recruiting |
NCT03160326 -
The QUALITY Vets Project: Muscle Quality and Kidney Disease
|
||
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02756520 -
Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
|
||
Withdrawn |
NCT02885545 -
The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
|
Phase 4 | |
Completed |
NCT02836574 -
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
|
Phase 2 | |
Completed |
NCT02875886 -
DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT02896309 -
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
|
N/A | |
Active, not recruiting |
NCT02483039 -
Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization
|
N/A | |
Completed |
NCT02992548 -
Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
|
Phase 4 | |
Terminated |
NCT02543177 -
Optimised Procedure in Patients With NSTEMI and CKD
|
N/A | |
Completed |
NCT02369549 -
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
|
Phase 3 | |
Recruiting |
NCT02205944 -
Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes
|
N/A | |
Active, not recruiting |
NCT02231138 -
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
|
Phase 4 |